Klaus Orlinger - 14 Apr 2023 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Scientific Officer
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Issuer symbol
HOOK
Transactions as of
14 Apr 2023
Net transactions value
$0
Form type
4
Filing time
18 Apr 2023, 19:50:46 UTC
Previous filing
01 Jul 2022
Next filing
17 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +194,200 $0.000000 194,200 14 Apr 2023 Common Stock 194,200 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on February 15, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.